The size of India’s cardiac and anti-diabetes drug markets has witnessed significant expansion, more than tripling in the past decade, according to a new report by Pharmarack. The report indicates that the anti-diabetes market, which was valued at approximately Rs 5,000 crore in 2014, has surged to nearly Rs 17,000 crore today.
Read MoreThe event included detailed discussions on the anatomical understanding, diagnosis, and management of various heart valves, including mitral, aortic, tricuspid, pulmonary, and common AV valve repairs in children
Read More